Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
6
×
glaxosmithkline
6
×
life sciences
national
6
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
biogen
bristol-myers squibb
clinical trials
abbvie
cancer
deals
duchenne muscular dystrophy
eli lilly
fda
gene therapy
merck
What
bio
6
×
roundup
cancer
crispr
days
drug
drugs
opioid
abbvie’s
acquisitions
advanced
albert
alliance
appetite
arrival
august
award
barbecuing
biggest
biotech
black
bourla
bread
bristol
busy
butter
buy
buyout
calls
camping
cardiologist
cash
center
ceo
changing
check
cholesterol
color
company
conference
Language
unset
unknown
Current search:
glaxosmithkline
×
bio
×
national
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More